David Alonso-Escolano Selected Research

L 796449

9/2005

The nonthiazolidinedione PPARgamma agonist L-796,449 is neuroprotective in experimental stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Alonso-Escolano Research Topics

Disease

2	Schizophrenia (Dementia Praecox) 05/2010 - 01/2008
2	Neoplasms (Cancer) 07/2006 - 12/2004
2	Breast Neoplasms (Breast Cancer) 07/2006 - 01/2004
2	Stroke (Strokes) 01/2006 - 09/2005
1	Thrombosis (Thrombus) 11/2005
1	Infarction (Infarctions) 09/2005
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2005

Drug/Important Bio-Agent (IBA)

2	Antipsychotic Agents (Antipsychotics)IBA 05/2010 - 01/2008
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2008
1	Peptide Hydrolases (Proteases)FDA Link 07/2006
1	Protein Synthesis InhibitorsIBA 07/2006
1	Protein Kinase C-deltaIBA 07/2006
1	ferric chlorideIBA 11/2005
1	CarbonIBA 11/2005
1	cyclopentenoneIBA 09/2005
1	2,4-thiazolidinedione (thiazolidinedione)IBA 09/2005
1	L 796449IBA 09/2005
1	ProstaglandinsIBA 09/2005
1	PPAR gammaIBA 09/2005
1	Biological ProductsIBA 12/2004
1	Adenosine Diphosphate (ADP)IBA 01/2004
1	Matrix Metalloproteinases (MMPs)IBA 01/2004
1	progelatinaseIBA 01/2004
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2004
1	Glycoproteins (Glycoprotein)IBA 01/2004
1	Integrin alphaVbeta3IBA 01/2004

Therapy/Procedure

2	Injections 05/2010 - 01/2008
1	Therapeutics 01/2006